ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,000 | +5.4% | 1,455,000 | +38.6% | 2.60% | +31.4% |
| Q2 2023 | $1,931,816 | +1.9% | 1,049,900 | +34.5% | 1.98% | -0.3% |
| Q1 2023 | $1,896,637 | +232902.1% | 780,509 | +37.2% | 1.99% | +109.5% |
| Q4 2022 | $814 | -99.9% | 569,000 | +1.7% | 0.95% | -33.6% |
| Q3 2022 | $1,248,000 | +7.8% | 559,500 | 0.0% | 1.43% | +6.7% |
| Q2 2022 | $1,158,000 | -19.6% | 559,500 | +12.6% | 1.34% | +7.8% |
| Q1 2022 | $1,441,000 | +115.7% | 496,805 | +138.8% | 1.24% | +111.6% |
| Q4 2021 | $668,000 | – | 208,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |